I'm a little more optimistic. The most common belief expressed among doctors that I've seen comment is that herd (community) immunity occurs at roughly 70% immunity. It does not matter how the immunity is acquired. I've seen no polls that say as many as 30% of people have already decided against the vaccine, but even if it's a little over 30%, the immunity acquired by people who've had it will push the overall number over the herd immunity threshold. The question is, how safe and effective will the vaccine be?
Some doctors on vumedi.com have expressed a concern that there is already a concerning level of distrust of vaccines in the population at large. If the coronavirus vaccine is given to 200 million people and kills just 0.001% of them, then it has still killed 2000 people. If it kills 1 in 10,000, then it will have killed 20,000 people. That's a lot fewer than the disease has killed, but when you lay that many bodies at the feet of a vaccine, you could end up with huge numbers of people turning away from all vaccines.
With my Systems Engineering hat on I have to call this the worst-case-scenario of competing requirements. They have to develop it fast, but the consequences of a mistake are incredibly dire. We Systems Engineers like to say "you can have it fast, cheap, good: choose 2". This is a situation where we don't care about the cost, but both "fast" and "good" are extremely important.
While we're on the subject, feel free to talk about how the vaccine is going to be paid in the poli thread. It is a given that it is going to be very expensive to develop, especially to develop and test it as fast as is necessary. How that will be paid for is a political discussion. Have fun with that.
Alright so... I couldn't find the original article from earlier this month but I think this is the study...
https://www.nature.com/articles/s41586-020-2550-z
Abstract in part:
Memory T cells induced by previous pathogens can shape the susceptibility to, and clinical severity of, subsequent infections1. Little is known about the presence of pre-existing memory T cells in humans with the potential to recognize SARS-CoV-2. Here, we first studied T cell responses to structural (nucleocapsid protein, NP) and non-structural (NSP-7 and NSP13 of ORF1) regions of SARS-CoV-2 in COVID-19 convalescents (n=36). In all of them we demonstrated the presence of CD4 and CD8 T cells recognizing multiple regions of the NP protein. We then showed that SARS-recovered patients (n=23) still possess long-lasting memory T cells reactive to SARS-NP 17 years after the 2003 outbreak...
Then in the course of searching for that, I found this:
https://www.cnn.com/2020/07/30/health/t-cells-coronavirus-study-wellness/index.html
The new study involved analyzing blood samples from 18 Covid-19 patients, ages 21 to 81, and healthy donors, ages 20 to 64, based in Germany. The study found that T cells reactive to the coronavirus were detected in 83% of the Covid-19 patients.
So, I dunno how much you guys have been posting it here, but a lot of the immunity discussion has been shifting to T cells so, in the top one is a Singapore study where they ID that there are T-Cells in the population resistant to COVID 19, including SARS outbreak survivors who have memory T Cells from 17 years ago....
THen the next one is a study in Germany that puts the prevalence of said T-Cells at up to 35% (small sample size).
A good long while back I posted something similar about antibodies prevalence in Asia offering at least limited immunity based on exposure to SARS and other coronaviruses.
Now, why quote that along with the vaccine.
So, I think once the vaccine rolls out, the R naught will drop pretty quickly well below 1, because I think there's a pretty wide set of factors other than just 70% of people taking it...
So, first is, what is the population prevalence going to be by the end of the year... (I'm being kind of hypothetical here so if you don't like the numbers I'm good with that, not my point, big guesstimating)
If there are 7 million cases by the end of the year, CDC is saying we might only be catching 1 in 10 cases due to early issue, assyms etc... that by itself would be close to 20%... I think its high and we will see what more robust seroprevalence tests return, but at some point this part become important, even at 15% (These guys here estimate the undercount at a wonderfully wide 6 to 24 times... so if you're super optimistic 24 times 4 million is a big number
https://www.the-scientist.com/news-...dy-in-us-shows-vast-covid-19-undercount-67762) And this data is old right now but that NYC test put it at 23%, now of course nearly everywhere else is a long way from the NYC infections per X people, and I think we'd prefer not to get there but... maybe slowly places catch up.
Then you have these TCell immunity factors - Is 35% right? I dunno, but even if its 15% - there's another big chunk (and largely the point here is there shouldn't be much, if any overlap between those groups)
But for giggles, let's say with those 2 things you already have 30% of people with some meaningful protection...that's a big deal.
(obviously there's a whole lot of "we don't know which people already have protection" that's going on, so you don't get to say, just give some other 30% the vaccine, but what you will have is 30% of the people who may not run to the front of the line, probably don't actually need it, and you get to 60% a lot quicker that way)
Anyway, I'm having a mostly rotten day so, if I don't respond to comments on this, nothing personal, I probably shouldn't be posting at all.